Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurobiology of Disease

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nbd.2007.11.005PMID 18201889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS.

  2006cited by this paper
• Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

  2006cited by this paper
• Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo

  2006cited by this paper
• Thalidomide and Lenalidomide Extend Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice

  2006cited by this paper
• Absence of Tumor Necrosis Factor-α Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations

  2006cited by this paper
• Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.

  2006cited by this paper
• Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

  2006cited by this paper
• Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve.

  2005cited by this paper
• Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis

  2005cited by this paper
• Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse

  2005cited by this paper
• Characterization of the human GARP (Golgi associated retrograde protein) complex.

  2005cited by this paper
• Tumor necrosis factor‐α receptor 1 (p55) knockout only transiently decreases the activation of c‐Jun and does not affect the survival of axotomized dopaminergic nigral neurons

  2005cited by this paper
• Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories

  2004cited by this paper
• Glial activation and TNFR-I upregulation precedes motor dysfunction in the spinal cord of mnd mice.

  2004cited by this paper
• Immunohistochemical localization of TNFalpha and its receptors in the rodent central nervous system.

  2004cited by this paper
• MAPKs: new targets for neurodegeneration

  2003cited by this paper
• Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells.

  2003cited by this paper
• Changes in glial cell white matter AMPA receptor expression after spinal cord injury and relationship to apoptotic cell death.

  2003cited by this paper
• A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia

  2003cited by this paper
• Tumor Necrosis Factor and Motoneuronal Degeneration: An Open Problem

  2002cited by this paper
• Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2

  2002cited by this paper
• Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro.

  2002cited by this paper
• Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

  2002cited by this paper
• Glutamate transporters in the spinal cord of the wobbler mouse

  2001cited by this paper
• SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.

  2001cited by this paper
• Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

  2001cited by this paper
• Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays.

  2001cited by this paper
• Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death

  2001cited by this paper
• Differential microglial response to progressive neurodegeneration in the murine mutant wobbler

  2001cited by this paper
• Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration

  2000influential reference
• Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis.

  2000cited by this paper
• Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS

  2000cited by this paper
• Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse.

  1999cited by this paper
• LIF (AM424), a promising growth factor for the treatment of ALS.

  1998cited by this paper
• Neuroprotective effects of TNF binding protein in focal cerebral ischemia.

  1997cited by this paper
• Inhibition of Tumor Necrosis Factor and Amelioration of Brain Infarction in Mice

  1997cited by this paper
• TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF.

  1996cited by this paper
• Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury

  1996cited by this paper
• CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases.

  1996cited by this paper
• Tumor necrosis factor-alpha induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor.

  1995cited by this paper
• Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor on wobbler murine motor neuron disease

  1995influential reference
• Astrocytosis in wobbler mouse spinal cord involves a population of astrocytes which is glutamine synthetase-negative.

  1995cited by this paper
• Tumor necrosis factor‐α induces substance P in sympathetic ganglia through sequential induction of interleukin‐1 and leukemia inhibitory factor

  1995cited by this paper
• Signal transduction by tumor necrosis factor mediated by JNK protein kinases

  1994cited by this paper
• Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF.

  1994cited by this paper
• Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Atomic structure and chemistry of human serum albumin

  1993cited by this paper

• Occurrence of amyotrophic lateral sclerosis during TNF inhibitor treatment in inflammatory rheumatic disease. What are the relationships?

  2025cites this paper
• Elevated NLRP3 Inflammasome Activation Is Associated with Motor Neuron Degeneration in ALS

  2024cites this paper
• Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis

  2021influential citation
• Systemic administration of scAAV9-IGF1 extends survival in SOD1G93A ALS mice via inhibiting p38 MAPK and the JNK-mediated apoptosis pathway.

  2018cites this paper
• The Selective Glucocorticoid Receptor Modulator Cort 113176 Reduces Neurodegeneration and Neuroinflammation in Wobbler Mice Spinal Cord.

  2018cites this paper
• Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration.

  2017cites this paper
• Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα

  2017cites this paper
• Iron accumulation promotes TACE-mediated TNF-α secretion and neurodegeneration in a mouse model of ALS.

  2015cites this paper
• Amyotrophic Lateral Sclerosis: A Focus on Disease Progression

  2014cites this paper
• The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice.

  2014cites this paper
• Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.

  2014cites this paper
• The wobbler mouse, an ALS animal model

  2013cites this paper
• Steigerung des neurotoxischen Potentials von Mikroglia durch Expression einer ALS-assoziierten SOD1-Mutante

  2013cites this paper
• TNF-α triggers rapid membrane insertion of Ca(2+) permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury.

  2012cites this paper
• Neuroprotective Effects of Toll-Like Receptor 4 Antagonism in Spinal Cord Cultures and in a Mouse Model of Motor Neuron Degeneration

  2012cites this paper
• Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.

  2011cites this paper
• Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS.

  2011cites this paper
• Tumor Necrosis Factor-α (TNF-α) Regulates Shedding of TNF-α Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection

  2010cites this paper
• Tumour necrosis factor alpha induces rapid reduction in AMPA receptor‐mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration

  2010cites this paper
• Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration.

  2009cites this paper
• Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2*

  2009cites this paper
• Microglia in pathogenesis of amyotrophic lateral sclerosis: Microglia in pathogenesis of amyotrophic lateral sclerosis

  2009cites this paper
• Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron disease.

  2009cites this paper
• Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein.

  2009cites this paper
• Signaling by death receptors in the nervous system.

  2008influential citation
• A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.

  2008cites this paper